HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance.

Abstract
Oxymatrine (OMTR) is an anti-hepatitis drug used in China. Its mechanism of action is unknown. Recently, we found that OMTR inhibits hepatitis B virus (HBV) via down-regulating the expression of heat-stress cognate 70 (Hsc70), a host protein required for HBV DNA replication. Goal of this study was to assess the effect of OMTR on clinical HBV drug-resistance. OMTR monotherapy (oral, 12 months) reduced blood HBV DNA by 96% and HBeAg by 70% in the chronic hepatitis B (CHB) patients resistant to lamivudine (n = 17), equal to its efficacy in the naïve CHB cohort (n = 20). Liver biopsy study showed that OMTR treatment caused a decrease of Hcs70 mRNA in liver cells, parallel with a reduction of intracellular HBV DNA. Combination of lamivudine with OMTR (n = 15) (oral, 12 months) showed an enhanced anti-HBV effect as compared to lamivudine monotherapy (n = 25). The incidence of drug resistance against lamivudine in the combination group was significantly lower than that in the lamivudine group (1/15 vs 7/25; p<0.01). The results were further confirmed in vitro. Treatment of HBV(+) HepH2215 cells with sub-optimal dose of OMTR for 8 months suppressed HBV replication without inducing drug resistance, whereas lamivudine monotherapy caused drug-resistant mutation in 3 months. Combination of OMTR with lamivudine prevented HBV from developing drug resistance.
AuthorsYu-Ping Wang, Wei Zhao, Rong Xue, Zhen-Xian Zhou, Fei Liu, Yan-Xing Han, Gang Ren, Zong-Gen Peng, Shan Cen, Hong-Shan Chen, Yu-Huan Li, Jian-Dong Jiang
JournalAntiviral research (Antiviral Res) Vol. 89 Issue 3 Pg. 227-31 (Mar 2011) ISSN: 1872-9096 [Electronic] Netherlands
PMID21277330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Alkaloids
  • Antiviral Agents
  • DNA, Viral
  • HSC70 Heat-Shock Proteins
  • HSPA8 protein, human
  • Hepatitis B e Antigens
  • Quinolizines
  • Lamivudine
  • oxymatrine
Topics
  • Administration, Oral
  • Adult
  • Alkaloids (administration & dosage, pharmacology)
  • Antiviral Agents (administration & dosage, pharmacology)
  • Biopsy
  • China
  • DNA, Viral (blood)
  • Down-Regulation
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Gene Expression Profiling
  • HSC70 Heat-Shock Proteins (biosynthesis)
  • Hepatitis B e Antigens (blood)
  • Hepatitis B virus (drug effects)
  • Hepatitis B, Chronic (drug therapy)
  • Humans
  • Lamivudine (administration & dosage)
  • Liver (pathology)
  • Male
  • Middle Aged
  • Quinolizines (administration & dosage, pharmacology)
  • Treatment Outcome
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: